US.IQV · IQVIA

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.3,
      "details": {
        "atrPct": 3.193445155346903,
        "turnoverUsdM": 569.44657467977,
        "liquidityPoints": 0.6,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.8,
    "stopLevels": {
      "symbol": "US.IQV",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 254.2064,
      "strength_details": {
        "ma_score": 2,
        "atr_score": 1,
        "rsi_score": 3,
        "macd_score": 3,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.7,
      "stop_loss_percent": 6.4,
      "take_profit_price": 300.8029,
      "target_multiplier": 2.2,
      "technical_strength": 2.3,
      "take_profit_percent": 10.8
    },
    "positionPoints": 1.3,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.690963751470283,
    "stopLossPercent": 6.386890310693806,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 75.6,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 61.6,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 14
  },
  "market": {
    "ma20": 266.3375,
    "ma50": 264.5692,
    "close": 271.55,
    "prevClose": 273.6,
    "avgVolume20": 1365311,
    "volumeRatio": 1.54,
    "changePercent": -0.75
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 14,
    "details": {
      "ret_5d": 0.0138136265143316,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 14,
      "vcp_bonus": 0,
      "vol_ratio": 1.5896593678576978,
      "ret_points": 4,
      "vol_points": 6,
      "range_ratio": 2.179563216984368,
      "volat_points": 4,
      "day_range_pct": 0.06534708397521946,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 0,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 75.6,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.7,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 54,
        "contribution": 2.7
      },
      {
        "raw": 13.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 66,
        "contribution": 13.2
      },
      {
        "raw": 9.6,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 64,
        "contribution": 9.6
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 6.9,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 69,
        "contribution": 6.9
      },
      {
        "raw": 21.2,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 70.67,
        "contribution": 21.2
      },
      {
        "raw": 6,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 60,
        "contribution": 6
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 61.6,
    "details": [
      "基本面分析總分: 2.7/5分",
      "資金流分析總分: 13.2/20分",
      "市場環境分析總分: 9.6/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 6.9/10分",
      "技術信號分析總分: 21.2/30分",
      "情緒分析: 6/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.7,
      "資金流": 13.2,
      "市場環境": 9.6,
      "情緒分析": 6,
      "技術信號": 21.2,
      "風險管理": 6.9
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0.75,
          "debtPoints": 0.5,
          "marginPoints": 0,
          "turnoverUsdM": 569.44657467977,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "一般",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 2.4,
          "obvPoints": 4,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.IQV",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "一般",
        "items": {
          "vix": {
            "score": 1.8,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 18.39
            }
          },
          "trend": {
            "score": 1.7999999999999998,
            "details": {
              "qqq": {
                "ma20": 733.18400235,
                "ma50": 725.2621992000002,
                "name": "QQQ",
                "close": 721.23999,
                "points": 0.4
              },
              "spy": {
                "ma20": 770.4114959000001,
                "ma50": 767.5287948999999,
                "name": "SPY",
                "close": 769.65997,
                "points": 1.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 3.193445155346903,
          "atrPoints": 2,
          "cciPoints": 4,
          "vixPoints": 1.8,
          "marketTrendPoints": 1.7999999999999998
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "一般",
        "items": {
          "sentiment": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 5,
              "sentimentScoreRaw": 1.5
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 143240716,
                "url": "https://finnhub.io/api/news?id=87c29bb2d6355fc186c8c7a85ae11e9349e99a4601a21ff1aeeaacea70c6e777",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQVIA (NYSE:IQV) reported third-quarter results that exceeded the high end of its guidance ranges, supported by accelerating organic growth in its Commercial Solutions and R&D Solutions businesses, higher clinical win rates and strong free cash flow. Revenue totaled $4.43 billion, up 8.0% year",
                "category": "company",
                "datetime": 1793131466,
                "headline": "What IQVIA (IQV) Said on Its Q3 Earnings Call"
              },
              {
                "id": 143239606,
                "url": "https://finnhub.io/api/news?id=89fe18e360c2251994a7a62ae0d3ecbaff0e676b6e41131add4fffb488e0f683",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Revenue hit $4.4 billion with 8% growth; net new bookings surged 15% year over year.",
                "category": "company",
                "datetime": 1793124863,
                "headline": "IQVIA (IQV) Q3 2026 Earnings Call Transcript"
              },
              {
                "id": 143237727,
                "url": "https://finnhub.io/api/news?id=068d5c17ad31539d2ad1bc03e0bd4248f82ec955e57e0cfde3ba1e6e4ea7189f",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "IQV",
                "summary": "IQVIA Holdings Inc. (IQV) Q3 2026 Earnings Call October 27, 2026 9:00 AM EDTCompany ParticipantsKerri Joseph - Senior Vice President of Investor...",
                "category": "company",
                "datetime": 1793105394,
                "headline": "IQVIA Holdings Inc. (IQV) Q3 2026 Earnings Call Transcript"
              },
              {
                "id": 143234647,
                "url": "https://finnhub.io/api/news?id=2f20557819d035fee14d5f8411feb9c06d8f634d49626128c34871860ef97207",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Clinical research company IQVIA (NYSE: IQV) reported Q3 2026 results exceeding the market’s revenue expectations, with revenue up 8% year on year to $4.43 billion. The company expects the full year’s revenue to be around $17.43 billion, close to analysts’ consensus estimates. Its non-GAAP profit of $3.34 per share was 2% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1793102323,
                "headline": "IQVIA’s (NYSE:IQV) Q3 2026: beats on revenue"
              },
              {
                "id": 143234648,
                "url": "https://finnhub.io/api/news?id=081790e84c2270ce0b704e4139b05af07b7e5d621830f323e6f67a86471fbe7e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQVIA (IQV) delivered earnings and revenue surprises of +3.09% and +1.44%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1793099703,
                "headline": "IQVIA Holdings (IQV) Surpasses Q3 Earnings and Revenue Estimates"
              },
              {
                "id": 143195401,
                "url": "https://finnhub.io/api/news?id=6dafb1d9b540443ae582b0664f1e473ad69e063c810a58dff0a5db35746ef87e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Clinical research company IQVIA (NYSE: IQV) will be reporting results this Tuesday before market open. Here’s what to expect.",
                "category": "company",
                "datetime": 1793009207,
                "headline": "IQVIA (IQV) Q3 earnings report preview: what to look for"
              },
              {
                "id": 143136468,
                "url": "https://finnhub.io/api/news?id=61d209f0bc5bc1429bd3c0da5e028e8d9cdf23ac856aa4555e808c513fe77fb6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Broyhill Asset Management, a Charlotte-based firm, issued its third-quarter 2026 investor letter. The letter can be downloaded here. The Broyhill Equity Composite decreased by 0.3% in Q3, underperforming the MSCI All Country World Index, which gained 1.7%. For the first nine months of the year, the Composite returned 1.9%, compared to 13.4% for the Index. The […]",
                "category": "company",
                "datetime": 1792772455,
                "headline": "Locking in Gains: Portfolio Discipline Triggers IQVIA Holding (IQV) Trim After Q2 Beat"
              },
              {
                "id": 143135922,
                "url": "https://finnhub.io/api/news?id=1946202ebe5a03c4eb7292e528891be7cf52519512876853ce64c0404d66ab78",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Investment management company Vulcan Value Partners recently released its third-quarter 2026 investor letter. The letter can be downloaded here. The portfolio reported a strong quarter, with all strategies except Small Cap reporting positive absolute results, with Small Cap down about 1%. In the quarter, the Large Cap Composite (Net) returned 7.4%, the Small Cap Composite (Net) returned […]",
                "category": "company",
                "datetime": 1792770243,
                "headline": "From Headwinds to Full Valuation: The Disciplined Exit of IQVIA Holdings (IQV)"
              }
            ],
            "raw_source": [
              {
                "id": 143240716,
                "url": "https://finnhub.io/api/news?id=87c29bb2d6355fc186c8c7a85ae11e9349e99a4601a21ff1aeeaacea70c6e777",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQVIA (NYSE:IQV) reported third-quarter results that exceeded the high end of its guidance ranges, supported by accelerating organic growth in its Commercial Solutions and R&D Solutions businesses, higher clinical win rates and strong free cash flow. Revenue totaled $4.43 billion, up 8.0% year",
                "category": "company",
                "datetime": 1793131466,
                "headline": "What IQVIA (IQV) Said on Its Q3 Earnings Call"
              },
              {
                "id": 143239606,
                "url": "https://finnhub.io/api/news?id=89fe18e360c2251994a7a62ae0d3ecbaff0e676b6e41131add4fffb488e0f683",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Revenue hit $4.4 billion with 8% growth; net new bookings surged 15% year over year.",
                "category": "company",
                "datetime": 1793124863,
                "headline": "IQVIA (IQV) Q3 2026 Earnings Call Transcript"
              },
              {
                "id": 143238144,
                "url": "https://finnhub.io/api/news?id=5db3401fc3b8dbefd523b8eebfabd075f6d3a89d19e30a4ac5b2f2941db4e591",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Moby summary of IQVIA Holdings Inc.'s Q3 2026 earnings call",
                "category": "company",
                "datetime": 1793123419,
                "headline": "IQVIA Holdings Inc. Q3 2026 Earnings Call Summary"
              },
              {
                "id": 143235820,
                "url": "https://finnhub.io/api/news?id=ec15bdf4851a792ae439292288a5fac9f60167f1dcc111098126bcdd852e856d",
                "image": "",
                "source": "Fintel",
                "related": "IQV",
                "summary": "",
                "category": "company",
                "datetime": 1793110348,
                "headline": "IQVIA Holdings Inc. Reports Third-Quarter 2026 Revenue of $4,428 million and Raises Full-Year Guidance"
              },
              {
                "id": 143237235,
                "url": "https://finnhub.io/api/news?id=b5757f5e55d20813d6502866ed00dcf26b46036ec885a60ffac9d6cd24cf1eaf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQV's Q3'26 earnings beat estimates as revenues rise 8% y/y, led by strong clinical demand, robust R&D bookings and improved execution, prompting a view hike.",
                "category": "company",
                "datetime": 1793108520,
                "headline": "IQVIA Holdings Q3 Earnings Beat Estimates, Revenues Increase 8% Y/Y"
              },
              {
                "id": 143233657,
                "url": "https://finnhub.io/api/news?id=989a6a14a4c8194858f23373acd4391ecaedabeef8547d64e87724082895003b",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "IQV",
                "summary": "S&P 500 premarket movers: Royal Caribbean and S&P Global lead gainers, while Xylem and Sherwin-Williams lead decliners ahead of the open.",
                "category": "company",
                "datetime": 1793108192,
                "headline": "S&P 500 Premarket Movers: Royal Caribbean, S&P Global Gain; Xylem, Sherwin-Williams Fall"
              },
              {
                "id": 143237727,
                "url": "https://finnhub.io/api/news?id=068d5c17ad31539d2ad1bc03e0bd4248f82ec955e57e0cfde3ba1e6e4ea7189f",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "IQV",
                "summary": "IQVIA Holdings Inc. (IQV) Q3 2026 Earnings Call October 27, 2026 9:00 AM EDTCompany ParticipantsKerri Joseph - Senior Vice President of Investor...",
                "category": "company",
                "datetime": 1793105394,
                "headline": "IQVIA Holdings Inc. (IQV) Q3 2026 Earnings Call Transcript"
              },
              {
                "id": 143234647,
                "url": "https://finnhub.io/api/news?id=2f20557819d035fee14d5f8411feb9c06d8f634d49626128c34871860ef97207",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Clinical research company IQVIA (NYSE: IQV) reported Q3 2026 results exceeding the market’s revenue expectations, with revenue up 8% year on year to $4.43 billion. The company expects the full year’s revenue to be around $17.43 billion, close to analysts’ consensus estimates. Its non-GAAP profit of $3.34 per share was 2% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1793102323,
                "headline": "IQVIA’s (NYSE:IQV) Q3 2026: beats on revenue"
              },
              {
                "id": 143236752,
                "url": "https://finnhub.io/api/news?id=69a6a2680719509f1e33808156721d19d3139b7c6968d65180a6608f14b7417c",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "IQV",
                "summary": "2026-10-27. The following slide deck was published by IQVIA Holdings Inc.",
                "category": "company",
                "datetime": 1793101155,
                "headline": "IQVIA Holdings Inc. 2026 Q3 - Results - Earnings Call Presentation"
              },
              {
                "id": 143232325,
                "url": "https://finnhub.io/api/news?id=46d98ca54db15063be283750a037d6f7483b2a0f6e8c618f02782aaaa1277d62",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "(IQV) on Tuesday reported third-quarter profit of $350 million.On a per-share basis, the Durham, North Carolina-based company said it had net income of $2.",
                "category": "company",
                "datetime": 1793099746,
                "headline": "IQVIA: Q3 Earnings Snapshot"
              },
              {
                "id": 143234648,
                "url": "https://finnhub.io/api/news?id=081790e84c2270ce0b704e4139b05af07b7e5d621830f323e6f67a86471fbe7e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQVIA (IQV) delivered earnings and revenue surprises of +3.09% and +1.44%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1793099703,
                "headline": "IQVIA Holdings (IQV) Surpasses Q3 Earnings and Revenue Estimates"
              },
              {
                "id": 143232326,
                "url": "https://finnhub.io/api/news?id=1a419f2fa439aa591f70cb8f81b472991867ca0d68be5398b16718f0753d6168",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "RESEARCH TRIANGLE PARK, N.C., October 27, 2026--IQVIA Holdings Inc. (\"IQVIA\") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today reported financial results for the quarter ended September 30, 2026.",
                "category": "company",
                "datetime": 1793098800,
                "headline": "IQVIA Reports Third-Quarter 2026 Results"
              },
              {
                "id": 143235526,
                "url": "https://finnhub.io/api/news?id=e2f6537904937063ca4c6b078b7dfed91605f18d6012b880b36cbf3d91555e42",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/27/Stock-market-chart-with-green-candlestic.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "IQV",
                "summary": "IQVIA Hldgs (NYSE:IQV) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. For",
                "category": "company",
                "datetime": 1793095644,
                "headline": "IQVIA Hldgs Q3 2026 Earnings Call Transcript"
              },
              {
                "id": 143235527,
                "url": "https://finnhub.io/api/news?id=c6fdabaf8b687b57ed933eaf0b543125738a381c3619994ac1d905cfce99999c",
                "image": "",
                "source": "Benzinga",
                "related": "IQV",
                "summary": "IQVIA Holdings (NYSE:IQV) raises FY2026 Adj EPS guidance from $12.80-$13.00 to $12.90-$13.00 vs $12.96 analyst estimate. Raises FY2026 sales outlook from $17.275 billion-$17.475 billion to $17.350 billion-$17.500",
                "category": "company",
                "datetime": 1793084467,
                "headline": "IQVIA Holdings Raises FY2026 Adj EPS Guidance from $12.80-$13.00 to $12.90-$13.00 vs $12.96 Est; Raises FY2026 Sales Guidance from $17.275B-$17.475B to $17.350B-$17.500B vs $17.419B Est"
              },
              {
                "id": 143196846,
                "url": "https://finnhub.io/api/news?id=ce48ef883f67882a4307f4418299634ed7f64dd3b6c414d6b03cb073e5780273",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "For questions about this article or underlying research, email help@trefis.com.",
                "category": "company",
                "datetime": 1793018877,
                "headline": "What Happens To Tempus AI Stock If Its Cash Burn Continues?"
              },
              {
                "id": 143195401,
                "url": "https://finnhub.io/api/news?id=6dafb1d9b540443ae582b0664f1e473ad69e063c810a58dff0a5db35746ef87e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Clinical research company IQVIA (NYSE: IQV) will be reporting results this Tuesday before market open. Here’s what to expect.",
                "category": "company",
                "datetime": 1793009207,
                "headline": "IQVIA (IQV) Q3 earnings report preview: what to look for"
              },
              {
                "id": 143136468,
                "url": "https://finnhub.io/api/news?id=61d209f0bc5bc1429bd3c0da5e028e8d9cdf23ac856aa4555e808c513fe77fb6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Broyhill Asset Management, a Charlotte-based firm, issued its third-quarter 2026 investor letter. The letter can be downloaded here. The Broyhill Equity Composite decreased by 0.3% in Q3, underperforming the MSCI All Country World Index, which gained 1.7%. For the first nine months of the year, the Composite returned 1.9%, compared to 13.4% for the Index. The […]",
                "category": "company",
                "datetime": 1792772455,
                "headline": "Locking in Gains: Portfolio Discipline Triggers IQVIA Holding (IQV) Trim After Q2 Beat"
              },
              {
                "id": 143135922,
                "url": "https://finnhub.io/api/news?id=1946202ebe5a03c4eb7292e528891be7cf52519512876853ce64c0404d66ab78",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Investment management company Vulcan Value Partners recently released its third-quarter 2026 investor letter. The letter can be downloaded here. The portfolio reported a strong quarter, with all strategies except Small Cap reporting positive absolute results, with Small Cap down about 1%. In the quarter, the Large Cap Composite (Net) returned 7.4%, the Small Cap Composite (Net) returned […]",
                "category": "company",
                "datetime": 1792770243,
                "headline": "From Headwinds to Full Valuation: The Disciplined Exit of IQVIA Holdings (IQV)"
              },
              {
                "id": 143124090,
                "url": "https://finnhub.io/api/news?id=48b0296580744c001ef19bbae703f3488d22b3072c8743b900b7a0600eec2d74",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "For questions about this article or underlying research, email help@trefis.com.",
                "category": "company",
                "datetime": 1792742633,
                "headline": "Guidance Up, Trend Intact: Veeva Is Today's Double-Confirmation Stock"
              },
              {
                "id": 143102751,
                "url": "https://finnhub.io/api/news?id=4638bf718d79d6b8f2f424206df2e0048d9bd5ebd128ad48667c3b95a84bbc91",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQV is poised for y/y revenue and earnings growth in Q3, driven by stronger clinical research demand, solid bookings, AI adoption and operational efficiencies.",
                "category": "company",
                "datetime": 1792673880,
                "headline": "IQVIA Gears Up to Post Q3 Earnings: Here's What Investors Should Know"
              },
              {
                "id": 143165796,
                "url": "https://finnhub.io/api/news?id=06c955c7d7966a4c49e7a996c5d8937732c88044f99740bf9deffb335d7fe874",
                "image": "https://image.cnbcfm.com/api/v1/image/108447488-17926871591792687157-49165085607-1080pnbcnews.jpg?v=1792687159&w=1920&h=1080",
                "source": "CNBC",
                "related": "IQV",
                "summary": "Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's 'Halftime Report' to spotlight IQVIA in his 'Best Stocks in the Market.'",
                "category": "company",
                "datetime": 1792672894,
                "headline": "Josh Brown's 'Best Stocks in the Market:' IQVIA"
              },
              {
                "id": 143069901,
                "url": "https://finnhub.io/api/news?id=6dda6705ba8996c394c3247f1672b191fa75ec34e6a89d6f57d653ac7def8831",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "For questions about this article or underlying research, email help@trefis.com.",
                "category": "company",
                "datetime": 1792593375,
                "headline": "Is Veeva Systems Stock Really Expensive?"
              },
              {
                "id": 143070272,
                "url": "https://finnhub.io/api/news?id=f79e2d1ad8126d7c0bac4a272766f185263d5e561a3817739bf35240d8378163",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "AxoGen (AXGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1792587618,
                "headline": "AxoGen (AXGN) Reports Next Week: Wall Street Expects Earnings Growth"
              },
              {
                "id": 143029137,
                "url": "https://finnhub.io/api/news?id=d8730424df8d510090ff0c49b9391e6cd07dbe706285a530c08e22ed9e3ef449",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1792501211,
                "headline": "IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy?"
              },
              {
                "id": 143028649,
                "url": "https://finnhub.io/api/news?id=8a501c9f056e2f99079d9467663f49f735be8b455c0d2f6bbf86a9769b5bcbc0",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1217886702/image_1217886702.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "IQV",
                "summary": "IQVIA (IQV) earns a Buy rating on strong Q2 results and R&D bookings recovery. See growth drivers, AI upside, key risks, and $285–$305 target.",
                "category": "company",
                "datetime": 1792495313,
                "headline": "IQVIA: R&D Bookings Are Reaccelerating, But The Valuation Now Requires Execution"
              },
              {
                "id": 143022444,
                "url": "https://finnhub.io/api/news?id=af538dfcc97471b773c0a98f306b8165f5d21902ddab715372966219658fcc87",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Tempus AI (TEM) stock has lost 17.3% over the past month, while the S&P 500 gained 0.6%. The company still grew sales 22% in its latest quarter, but the risk worth your attention lies with the few drugmakers that license its data. One of them is a very large client. Which drugmaker is it, and how long does its deal with Tempus AI run.",
                "category": "company",
                "datetime": 1792494180,
                "headline": "Should You Be Worried About Tempus AI Stock?"
              },
              {
                "id": 143021507,
                "url": "https://finnhub.io/api/news?id=5d3e2ec8b9dce3cb9c504c648d07799eb4607365fdf6b0de5602c8b0160923b5",
                "image": "https://www.chartmill.com/images/uploads/CM_Breakout_Stocks_Small_free_bb09e243c7.webp",
                "source": "ChartMill",
                "related": "IQV",
                "summary": "IQVIA (IQV) earns 9/10 technical and setup ratings, consolidating near 52-week highs. See breakout entry, support, resistance, and key risks.",
                "category": "company",
                "datetime": 1792486835,
                "headline": "IQVIA HOLDINGS INC (NYSE:IQV) Sets Up for Breakout With Strong Technical Ratings"
              },
              {
                "id": 143005843,
                "url": "https://finnhub.io/api/news?id=c8ed0fc7bb83262d8f415b8ec68c76a0cf1bac3e98bee31285b4f56aefdb1e2c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.",
                "category": "company",
                "datetime": 1792405015,
                "headline": "1 Large-Cap Stock to Research Further and 2 We Avoid"
              },
              {
                "id": 142945849,
                "url": "https://finnhub.io/api/news?id=2b535b916db50d514fe2cba85851d73a14315176b2bd26633c1647b7a2a35b90",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.",
                "category": "company",
                "datetime": 1792156539,
                "headline": "3 Low-Volatility Stocks with Questionable Fundamentals"
              },
              {
                "id": 142944734,
                "url": "https://finnhub.io/api/news?id=c519c7554eb32755c5657c83921c21b82c985fea2d77fb3678ba1744c7f4e4e0",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1213764535/image_1213764535.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "IQV",
                "summary": "IQVIA Holdings (IQV) reported robust Q2 2026 results, with 8.7% revenue growth and a 19% increase in Research & Development Solutions bookings.",
                "category": "company",
                "datetime": 1792137966,
                "headline": "IQVIA: A $34.2 Billion Backlog Does Not Guarantee Faster Earnings Growth"
              },
              {
                "id": 142919501,
                "url": "https://finnhub.io/api/news?id=fd8f9c53e8c6614f449f2d6fac11ba762a6e5bbf3b1dbf1751db6246041a786e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Harris Oakmark recently released its third-quarter 2026 investor letter for its “Oakmark Global Fund”. The letter can be downloaded here. The Fund (Investor Class) returned 1.68% for the quarter, slightly trailing the MSCI World Index’s 1.88% return. Key performance contributors included information technology and financials, while consumer discretionary and industrials detracted. Regional allocations were predominantly 50.6% […]",
                "category": "company",
                "datetime": 1792076753,
                "headline": "IQVIA Holdings (IQV) Gains as Improving Demand Environment and High Win Rates"
              },
              {
                "id": 142885265,
                "url": "https://finnhub.io/api/news?id=3eb31bac32bc70e5f4b3ef4579a9d9893f7b510e98275dea2b52506cf6365294",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Veeva expands its IQVIA partnership with clinical operations software, boosting its market reach and growth prospects through wider adoption and integrated workflows.",
                "category": "company",
                "datetime": 1791985440,
                "headline": "VEEV Expands IQVIA Partnership With Clinical Operations Software Suite"
              },
              {
                "id": 142883692,
                "url": "https://finnhub.io/api/news?id=80efc39937055566bfeb4449c093cc0f6634cdd80ae641dc6efd1d31f396a670",
                "image": "",
                "source": "Benzinga",
                "related": "IQV",
                "summary": "Stifel  analyst Shlomo Rosenbaum   maintains IQVIA Holdings (NYSE:IQV) with a Buy and raises the price target from $276 to $303.",
                "category": "company",
                "datetime": 1791963863,
                "headline": "Stifel Maintains Buy on IQVIA Holdings, Raises Price Target to $303"
              },
              {
                "id": 142964734,
                "url": "https://finnhub.io/api/news?id=13dee50593cac182c15909c32d92e15885761059e41aaec30d0a4faf9a4b6d05",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "RESEARCH TRIANGLE PARK, N.C. & PLEASANTON, Calif., October 13, 2026--IQVIA (NYSE:IQV) and Veeva Systems (NYSE: VEEV) today announced an expansion of their partnership with the selection of Veeva CTMS, eTMF, Study Startup, and Site Connect as enterprise standard applications that will be used across IQVIA clinical development studies. This extends the previously announced EDC partnership.",
                "category": "company",
                "datetime": 1791889380,
                "headline": "IQVIA Selects Veeva Clinical Operations Applications"
              },
              {
                "id": 142849996,
                "url": "https://finnhub.io/api/news?id=d1f4aa765e4582eb7dff3e9f33718aabe8cf5f0ee234a8e5235829586e84c64e",
                "image": "",
                "source": "Benzinga",
                "related": "IQV",
                "summary": "IQVIA (NYSE:IQV) and Veeva Systems (NYSE:VEEV) today announced an expansion of their partnership with the selection of Veeva CTMS, eTMF, Study Startup, and Site Connect as enterprise standard applications that will be",
                "category": "company",
                "datetime": 1791875729,
                "headline": "IQVIA Expands Partnership Veeva Systems On Enterprise Standard Applications That Will Be Used Across IQVIA Clinical Development Studies"
              },
              {
                "id": 142764323,
                "url": "https://finnhub.io/api/news?id=3b3344f74bcb61c4bd0118651c3f64969cb03c062ec7f3b9717f18bd5f79bca6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Tempus AI (TEM) stock returned 56.9% in the six months from April 9 to October 8, 2026. Partway through that timeline, on July 30, the company finally reported a quarterly profit following years of losses. Yet the stock's run began more than three months before that earnings report. Market moves of this scale always look obvious in hindsight. Had Tempus signaled that positive net income—or breakeven on an adjusted basis—was finally within reach.",
                "category": "company",
                "datetime": 1791555553,
                "headline": "Could You Have Seen The Run In Tempus AI Stock Coming?"
              },
              {
                "id": 142766407,
                "url": "https://finnhub.io/api/news?id=5948041bdd0d0af282f299ec0e1c9128f8a8966b45b6528df4d64df2a58d43e8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQVIA Holdings is all set to post its third-quarter earnings later this month and analysts expect a high-single-digit boost in its EPS.",
                "category": "company",
                "datetime": 1791548845,
                "headline": "IQVIA Holdings’ Quarterly Earnings Preview: What You Need to Know"
              },
              {
                "id": 142700259,
                "url": "https://finnhub.io/api/news?id=29bdde38ebf21ff4bd5f4980a2377e81dbeb1a6d4d36324890b62782b5e3b98b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "RESEARCH TRIANGLE PARK, N.C., October 07, 2026--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today at TechIQ 2026 introduced IQVIA Life Science ModelsTM to help predict clinical trial outcomes.",
                "category": "company",
                "datetime": 1791407340,
                "headline": "IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes"
              },
              {
                "id": 142700534,
                "url": "https://finnhub.io/api/news?id=e101adcd78e6af35b7b8e9b07ee4a05a132969db7c9ef08b2b238aae79be8696",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "RESEARCH TRIANGLE PARK, N.C., October 07, 2026--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today at TechIQ 2026 introduced IQVIA Explorer™ to help customers make better-informed commercial decisions.",
                "category": "company",
                "datetime": 1791404100,
                "headline": "IQVIA Launches IQVIA Explorer to Help Life Sciences Companies Make Better Commercial Decisions"
              },
              {
                "id": 142729269,
                "url": "https://finnhub.io/api/news?id=bbb41db74d0ce4d2fbc979816ad505cd279d8f1ee1e554173453d30576b33579",
                "image": "",
                "source": "Benzinga",
                "related": "IQV",
                "summary": "Mizuho  analyst Ann Hynes   maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $275 to $300.",
                "category": "company",
                "datetime": 1791382418,
                "headline": "Mizuho Maintains Outperform on IQVIA Holdings, Raises Price Target to $300"
              },
              {
                "id": 142729270,
                "url": "https://finnhub.io/api/news?id=c6c5285702868c4592d604832e70b3936f90afacd0393364eb4a1a7631785167",
                "image": "",
                "source": "Benzinga",
                "related": "IQV",
                "summary": "Barclays  analyst Luke Sergott   maintains IQVIA Holdings (NYSE:IQV) with a Overweight and raises the price target from $275 to $300.",
                "category": "company",
                "datetime": 1791370444,
                "headline": "Barclays Maintains Overweight on IQVIA Holdings, Raises Price Target to $300"
              },
              {
                "id": 142656275,
                "url": "https://finnhub.io/api/news?id=71cb7a6a5333f3b7ebf29f8922afebdbe07b52037c3e8d073f6ffff43c6f6003",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.",
                "category": "company",
                "datetime": 1791276994,
                "headline": "1 S&P 500 Stock with Competitive Advantages and 2 We Turn Down"
              },
              {
                "id": 142591052,
                "url": "https://finnhub.io/api/news?id=1c6f74d4856686304c0cb41d752634381ae64c2aee0d8c7f7427d612ef5f72f6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQV's vast healthcare database, AI-enabled capabilities and strong R&DS bookings support growth, while low liquidity and $14.1B net debt remain in focus.",
                "category": "company",
                "datetime": 1790951280,
                "headline": "Extensive Database & Solid Bookings Benefit IQVIA Amid Low Liquidity"
              },
              {
                "id": 142557261,
                "url": "https://finnhub.io/api/news?id=87be41588597d966a270c5058efcebbaa787e3f0de5b19a3f87ac7c268f6d23b",
                "image": "",
                "source": "Benzinga",
                "related": "IQV",
                "summary": "https://www.axios.com/2026/09/30/hhs-clinical-trials-redesign",
                "category": "company",
                "datetime": 1790781438,
                "headline": "'HHS launches project to speed up clinical trials' - Axios"
              },
              {
                "id": 142520169,
                "url": "https://finnhub.io/api/news?id=2d6d5a1edbb15d562b40bfbcd9735d10a249ceb0ee104e464a712878614ac742",
                "image": "",
                "source": "Benzinga",
                "related": "IQV",
                "summary": "UBS  analyst Kevin Caliendo   reinstates IQVIA Holdings (NYSE:IQV) with a Buy and announces $345 price target.",
                "category": "company",
                "datetime": 1790756352,
                "headline": "UBS Reinstates Buy on IQVIA Holdings, Announces $345 Price Target"
              },
              {
                "id": 142501566,
                "url": "https://finnhub.io/api/news?id=e402b6a0f4056fd9cf03bdfea8231722c082a935e7d317ea8cf8b9b217e3a867",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "RESEARCH TRIANGLE PARK, N.C., September 29, 2026--IQVIA Holdings Inc. (\"IQVIA\") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, will announce its third-quarter 2026 financial results before the market opens on Tuesday, October 27, 2026. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time that same day. The earnings release and accompany",
                "category": "company",
                "datetime": 1790712900,
                "headline": "IQVIA to Announce Third-Quarter 2026 Results on October 27, 2026"
              },
              {
                "id": 142495669,
                "url": "https://finnhub.io/api/news?id=40ddb97867da73cc4a66cafc2f245654c55f10dd57883217e6ecfe8ec11744cc",
                "image": "",
                "source": "Benzinga",
                "related": "IQV",
                "summary": "RBC Capital  analyst Ryan Halsted   maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $247 to $319.",
                "category": "company",
                "datetime": 1790670838,
                "headline": "RBC Capital Maintains Outperform on IQVIA Holdings, Raises Price Target to $319"
              },
              {
                "id": 142495670,
                "url": "https://finnhub.io/api/news?id=0a02f23922976530f1f81bbe36aa1dd211974e9a93fffa7ce58ee72b2fde75e2",
                "image": "",
                "source": "Benzinga",
                "related": "IQV",
                "summary": "Truist Securities  analyst Jailendra Singh   reiterates IQVIA Holdings (NYSE:IQV) with a Buy and raises the price target from $300 to $329.",
                "category": "company",
                "datetime": 1790594002,
                "headline": "Truist Securities Reiterates Buy on IQVIA Holdings, Raises Price Target to $329"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 5,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.5,
            "source_article_count": 48,
            "discarded_article_count": 37
          },
          "sentimentPoints": 6
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 21.2,
        "grade": "良好",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 0.9,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 0.9,
            "vcp_reason": "站上MA50；升放量(近10日3日)；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 6,
              "vol_ref": 1513913.3333333333,
              "down_days": 3,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 1359290,
              "avg_vol_20": 1319165,
              "avg_vol_30": 1513913.3333333333,
              "range_pct_10": 0.08606157562370012,
              "range_pct_20": 0.11202360935457958,
              "range_pct_30": 0.11202360935457958,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": false,
              "up_expand_days": 3,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.8978651353886397,
              "dist_to_20d_high": 0.040391616354809,
              "down_shrink_days": 2,
              "breakout_level_20d": 282.98001,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.768244980853064
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 2.4,
          "shortRsiPoints": 1,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.3,
            "details": {
              "atrPct": 3.193445155346903,
              "turnoverUsdM": 569.44657467977,
              "liquidityPoints": 0.6,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.8,
          "stopLevels": {
            "symbol": "US.IQV",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 254.2064,
            "strength_details": {
              "ma_score": 2,
              "atr_score": 1,
              "rsi_score": 3,
              "macd_score": 3,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.7,
            "stop_loss_percent": 6.4,
            "take_profit_price": 300.8029,
            "target_multiplier": 2.2,
            "technical_strength": 2.3,
            "take_profit_percent": 10.8
          },
          "positionPoints": 1.3,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.690963751470283,
          "stopLossPercent": 6.386890310693806,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 8.6718,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 3.19
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "強勢區",
      "score": 10,
      "value": 96.78
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.054
    },
    "kdj": {
      "d": 68.82,
      "j": 50.47,
      "k": 62.7,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "平衡",
      "score": 6,
      "value": 58.99
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 6035277,
      "recentSlope": 189727.7,
      "previousSlope": -86220
    },
    "rsi": 65.83,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 262.4177,
      "position": "SAR喺價下",
      "distancePct": 3.36,
      "previousTrend": "上升"
    },
    "ma50": 264.5692,
    "macd": {
      "macd": 3.352621674335637,
      "trend": "強烈看漲",
      "signal": 2.545806795095702,
      "histogram": 0.8068148792399352
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 267.2104,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 9
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.54,
      "score": 6,
      "avgVolume": 1365311,
      "currentVolume": 2097023
    },
    "derived": {
      "ma20": 266.3375,
      "ma50": 264.5692,
      "prevClose": 273.6,
      "avgVolume10": 1433022,
      "avgVolume20": 1365311,
      "changePercent": -0.75,
      "avgVolumeForScore": 1365311
    },
    "ma_cross": {
      "ma20": 266.3375,
      "ma50": 264.5692,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "接近",
      "score": 6,
      "prevMa20": 266.2095,
      "prevMa50": 263.963,
      "spreadPct": 0.67,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 252.9127,
      "upper": 279.7623,
      "position": "上半部"
    },
    "rsi_short": 63.32,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.54
    }
  }
}

{
  "close": 271.55,
  "volume": 2097023,
  "changePercent": -0.75
}